COMMUNIQUÉS West-GlobeNewswire

-
Atara Biotherapeutics Announces Third Quarter 2018 Financial Results and Recent Operational Progress
06/11/2018 -
Kura Oncology to Participate in Two Upcoming Investor Conferences
06/11/2018 -
OpGen Completes Specimen Accrual and Testing in Acuitas® Clinical Verification Study
06/11/2018 -
Spark Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Progress
06/11/2018 -
Otonomy Presents Data Highlighting Potential of OTO-413, an Otic Sustained-Exposure Formulation of BDNF, to Treat Hearing Loss
06/11/2018 -
Vericel Reports Record Third Quarter Revenues of $22.5 Million and Raises Full Year 2018 Revenue Guidance
06/11/2018 -
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
06/11/2018 -
Veteran Oncology Biotechnology Executive and Third Rock Ventures Entrepreneur in Residence Markus Warmuth, MD, Joins IMV Inc. Board of Directors
06/11/2018 -
AxoGen to Host Third Annual Analyst and Investor Day on November 19, 2018
06/11/2018 -
Cyclacel Pharmaceuticals to Release Third Quarter 2018 Financial Results
06/11/2018 -
Microbix Exhibiting at MEDICA Trade Fair
06/11/2018 -
G1 Therapeutics to Present at Investor Conferences in November 2018
06/11/2018 -
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
06/11/2018 -
Akcea Therapeutics to Present at Upcoming Investor Conferences
06/11/2018 -
InspireMD Announces Third Quarter 2018 Financial Results and Provides Corporate Update
06/11/2018 -
RedHill Biopharma to Host Third Quarter 2018 Financial Results Conference Call on November 13, 2018
06/11/2018 -
Capricor Therapeutics to Present Third Quarter Financial Results and Corporate Update on November 13
06/11/2018 -
Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
06/11/2018 -
Tonix Pharmaceuticals Presented Results and Retrospective Analyses of Phase 3 P301 “HONOR” Study in Poster Presentation at CNS Summit 2018
06/11/2018
Pages